"PAI is a market leader in RTU oral liquid medicines, and that same focus on quality, reliability, and patient-centric design carries naturally into RTU injectables," said Kurt Orlofski, CEO of PAI ...

Daiichi Sankyo plans to splash out some 300 billion yen ($1.9 billion) on Enhertu manufacturing facilities across the globe, ...

Companies are facing a situation where they need to fill their pipelines, but also navigate a competitive environment for the ...

Supply chains are being diversified and regionalized to mitigate global disruptions, with significant investments in US ...

Sharp Sterile Manufacturing is investing $28 million to expand its site in Lee, Massachusetts, which offers a range of ...

The year 2025 was defined by escalating global trade tensions that fundamentally reshaped the pharmaceutical supply chain, ...

The pharmaceutical industry relies heavily on its supply chain, but this chain can also have a significant environmental impact due to common factors like high emissions or packaging waste.

Alnylam Pharmaceuticals has announced a $250 million investment to expand its manufacturing facility in Massachusetts. The ...

Robinson Pharma expands manufacturing in Santa Ana with a high-speed liquid production line and added tablet, capsule and ...

Low compliance by the country’s 8,500 small and medium enterprises (MSMEs) manufacturing pharmaceuticals would raise the risk ...

The biopharma industry has spent much of this year grappling with fast-moving changes related to the Trump administration's trade policies. On Thursday, without warning, came another jolt. “Starting ...

Pharma industry leaders spotlight quality, sustainability and market diversification as export priorities for 2026: Our ...